Position in MGNX
as of Mar 31, 2026
· filed May 5, 2026
Position Value
$855,688
+$663,380 QoQ
Shares Held
296,086
+147.9% QoQ
Ownership
0.466%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MGNX Over Time
Shares Held
Position Value (USD)
Derivatives in MGNX
reported options exposure · as of Sep 30, 2024CallValue
$65,800
CallShares
20,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026UBS Group AG holds $8,307,109,707 across 562 Biotechnology names. MGNX ranks #254 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ROIV |
Roivant Sciences Ltd.
|
22,619,472 | $626,559,372 | |
| 2 | PTGX |
Protagonist Therapeutics, Inc
|
5,177,796 | $545,739,697 | |
| 3 | ABVX |
Abivax S.A.
|
4,547,406 | $506,353,656 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
4,386,791 | $426,615,424 | |
| 5 | INSM |
INSMED Inc
|
1,737,481 | $284,112,890 | |
| 6 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
630,618 | $281,596,158 | |
| 7 | APLS |
Apellis Pharmaceuticals, Inc.
|
6,206,681 | $249,694,775 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
299,979 | $231,775,770 |
All Filings in MGNX
Export CSV
27 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $855,688 | 296,086 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $192,308 | 119,447 | Shares | Defined | 2026-01-29 | |
| 2025-09-30 | $80,280 | 47,786 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $52,806 | 43,642 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $47,857 | 37,684 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $552,366 | 169,959 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $282,977 | 86,012 | Shares | Defined | 2024-11-14 | |
| 2024-09-30 | $65,800 | 20,000 | Call | Defined | 2024-11-14 | |
| 2024-06-30 | $363,548 | 85,541 | Shares | Defined | 2024-08-14 | |
| 2024-06-30 | $85,000 | 20,000 | Call | Defined | 2024-08-14 | |
| 2024-03-31 | $3,803,044 | 258,359 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $1,279,565 | 133,011 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $468,194 | 100,471 | Shares | Defined | 2023-11-09 | |
| 2023-06-30 | $564,199 | 105,458 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $539,283 | 75,214 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $473,041 | 70,498 | Shares | Defined | 2023-02-08 | |
| 2022-09-30 | $236,026 | 68,216 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $177,996 | 60,338 | Shares | Defined | 2022-08-10 | |
| 2022-03-31 | $1,205,102 | 136,788 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $2,226,583 | 138,728 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $854,980 | 40,830 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $746,815 | 27,804 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $1,854,880 | 58,238 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $31,021 | 1,357 | Shares | Defined | 2021-02-11 | |
| 2020-09-30 | $22,242 | 883 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $116,621 | 4,177 | Shares | Defined | 2020-07-31 | |
| 2020-03-31 | $60,690 | 10,428 | Shares | Defined | 2020-05-01 | |
| No filing history on record for this holder in this stock. | ||||||